Eye Complications for Cancer Therapy
Trial Summary
What is the purpose of this trial?
The purpose of this study is to collect data on patients seen at University of Maryland after undergoing cancer therapy. Previous medications, ocular history, medical history, clinical evaluations, surgical procedures and outcomes will be gathered on the patients who consent to participate. Potential subjects will be enrolled from the clinical practice of the investigator at the time of their eye examination visit. A standard of care exam will be performed pertinent to the reason for the visit. In addition to the standard of care exam, certain biological specimens (ocular surface wash, mucocellular material, corneal filaments, impression cytology, and/or blood) will be collected, stored, and analyzed to obtain immunologic, cellular, or molecular mechanistic insights into disease pathogenesis.
Eligibility Criteria
This trial is for adults over 18 who've had a stem cell transplant or cancer therapy and are seeing an eye doctor at the University of Maryland. They shouldn't have a history of serious eye diseases, except mild dry eye or past surgeries like cataract removal.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants undergo an eye exam and research protocols such as tear collection, impression cytology, and blood collection
Follow-up
Participants are monitored for ocular complications and outcomes post-cancer therapy
Treatment Details
Interventions
- Eye exam
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor